title: Clinton Foundation negotiates $140/Year HIV treatment, but U.S. won't buy.
abstract: The Clinton Foundation, World Bank, UNICEF, and the Global Fund to Fight AIDS, Tuberculosis, and Malaria announced that they could negotiate prices as low as $140 per year for triple-combination antiretroviral therapy. But the Bush Administration is refusing to buy generic medicines for its major HIV treatment program.
authors.forename: John S
authors.initials: JS
authors.lastname: James
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D005582:Foundations; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D017008:Negotiating; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019380:Anti-HIV Agents